ProShare Advisors
BNTX icon

ProShare Advisors’s BioNTech BNTX Stock Holding History

ProShare Advisors’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$355K Sell
3,812
-1,284
-25% -$121K ﹤0.01% 1317
2026
Q1 		$453K Buy
5,096
+632
+14% +$64.9K ﹤0.01% 1121
2025
Q4 		$425K Buy
4,464
+880
+25% +$88.7K ﹤0.01% 1226
2025
Q3 		$353K Sell
3,584
-146
-4% -$15.6K ﹤0.01% 1316
2025
Q2 		$397K Sell
3,730
-758
-17% -$76.6K ﹤0.01% 1252
2025
Q1 		$409K Sell
4,488
-164
-4% -$18.4K ﹤0.01% 1205
2024
Q4 		$530K Sell
4,652
-1,141
-20% -$130K ﹤0.01% 1239
2024
Q3 		$688K Sell
5,793
-260
-4% -$23.9K ﹤0.01% 955
2024
Q2 		$486K Sell
6,053
-732
-11% -$66.9K ﹤0.01% 993
2024
Q1 		$626K Buy
6,785
+637
+10% +$61.1K ﹤0.01% 965
2023
Q4 		$649K Buy
6,148
+40
+0.7% +$4.03K ﹤0.01% 893
2023
Q3 		$664K Buy
6,108
+57
+0.9% +$6.3K ﹤0.01% 813
2023
Q2 		$653K Sell
6,051
-432
-7% -$48.6K ﹤0.01% 845
2023
Q1 		$808K Sell
6,483
-1,123
-15% -$154K ﹤0.01% 762
2022
Q4 		$1.14M Buy
7,606
+193
+3% +$29.7K ﹤0.01% 715
2022
Q3 		$1M Buy
7,413
+550
+8% +$84.1K ﹤0.01% 731
2022
Q2 		$1.02M Sell
6,863
-2,257
-25% -$345K ﹤0.01% 755
2022
Q1 		$1.56M Sell
9,120
-3,288
-26% -$552K ﹤0.01% 785
2021
Q4 		$3.2M Sell
12,408
-5,150
-29% -$1.41M 0.01% 666
2021
Q3 		$4.79M Buy
17,558
+3,309
+23% +$1.05M 0.01% 525
2021
Q2 		$3.19M Buy
14,249
+3,859
+37% +$728K 0.01% 605
2021
Q1 		$1.13M Buy
10,390
+151
+1% +$16K ﹤0.01% 915
2020
Q4 		$835K Buy
+10,239
New +$1.01M ﹤0.01% 964

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
GP
GSK plc London $602M AUM

ProShare Advisors's BNTX Position: Q2 2026 in Review

ProShare Advisors reduced its BioNTech (BNTX) stake by 25% in Q2 2026, selling an estimated $121K and leaving 3,812 shares worth $355K. The position accounts for ﹤0.01% of the portfolio, ranked #1317.

ProShare Advisors first reported a position in BNTX in Q4 2020 and has held it in 23 quarters since. The position peaked at $4.79M in Q3 2021. 283 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • ProShare Advisors held 3,812 shares of BioNTech worth $355K as of Q2 2026.
  • ProShare Advisors sold 1,284 BioNTech shares in Q2 2026, an estimated $121K.
  • BioNTech made up ﹤0.01% of ProShare Advisors's portfolio in Q2 2026, its #1317 holding.
  • ProShare Advisors first reported a position in BioNTech in Q4 2020 and has held it in 23 quarters since.
  • ProShare Advisors's BioNTech position peaked at $4.79M in Q3 2021.
  • 283 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on ProShare Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.